Division of Cardiac Surgery, Brigham and Women's Hospital, Boston, Massachusetts.
Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Ann Thorac Surg. 2020 Apr;109(4):1194-1201. doi: 10.1016/j.athoracsur.2019.07.041. Epub 2019 Aug 31.
Adverse repercussions associated with the current opioid epidemic have been documented in many surgical specialties. This study evaluated the impact of opioid use disorder (OUD) on in-hospital cardiac surgery outcomes by using a large national database.
Using the National Inpatient Sample, this study isolated patients undergoing coronary artery bypass grafting, valve repair, or valve replacement from 2009 to 2014. Patients were stratified by OUD status. Multivariable analysis was performed to evaluate the association between opioid use and postoperative outcomes. Patients were further stratified by surgery type.
Overall, 1,743,161 patients underwent cardiac surgery, and 6960 patients had OUD (0.4%). Mean age was 47.2 and 65.8 years among those with and without OUD, respectively. Although in-hospital mortality did not differ among these groups, patients with OUD had a significantly higher incidence of stroke (8.3% vs 2.8%) and acute kidney injury (21.4% vs 16.2%), longer hospital stays (18 days vs 10 days), and higher hospitalization costs ($81,238 vs $58,654; all P < .01). However, after adjusting for patient and hospital-level factors, OUD was associated only with a longer hospital length of stay (2.2 days; 95% confidence interval, 1.19 to 3.20) compared with non-opioid users.
OUD among cardiac surgery patients is associated with prolonged hospitalization and increased risk of postoperative morbidity, mainly driven by the patient's preoperative risk factors. Strategies to minimize these risk factors at the prehospitalization level is warranted to curb the opioid epidemic and improve overall outcomes in this vulnerable population.
在许多外科专业中,都有与当前阿片类药物流行相关的不良后果的记录。本研究使用大型国家数据库评估了阿片类药物使用障碍(OUD)对住院心脏手术结果的影响。
本研究使用国家住院患者样本,从 2009 年至 2014 年,将接受冠状动脉旁路移植术、瓣膜修复或瓣膜置换术的患者分离出来。根据 OUD 状况对患者进行分层。进行多变量分析以评估阿片类药物使用与术后结果之间的关联。根据手术类型对患者进一步分层。
总体而言,有 1743161 例患者接受了心脏手术,6960 例患者患有 OUD(0.4%)。有和没有 OUD 的患者的平均年龄分别为 47.2 岁和 65.8 岁。尽管这些组之间的院内死亡率没有差异,但患有 OUD 的患者发生中风(8.3%对 2.8%)和急性肾损伤(21.4%对 16.2%)的发生率更高,住院时间更长(18 天对 10 天),住院费用更高(81238 美元对 58654 美元;均 P<.01)。然而,在校正了患者和医院水平的因素后,OUD 仅与非阿片类药物使用者相比,住院时间延长(2.2 天;95%置信区间,1.19 至 3.20)相关。
心脏手术患者中的 OUD 与住院时间延长和术后发病率增加有关,主要是由患者的术前危险因素驱动的。在住院前水平采取策略来最大限度地减少这些危险因素是遏制阿片类药物流行并改善这一脆弱人群总体结果的必要条件。